Cargando…

NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas

BACKGROUND: Photodynamic therapy (PDT) subsequent to surgical tumor removal is a novel light-activated localized treatment for malignant glioma. Although PDT provides effective local control, even PDT cannot completely suppress local recurrence of malignant glioma. We previously reported that the ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Yuichi, Nagashima, Hiroaki, Tanaka, Kazuhiro, Hashiguchi, Mitsuru, Itoh, Tomoo, Sasayama, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648157/ http://dx.doi.org/10.1093/noajnl/vdab159.070

Ejemplares similares

CBMS-5 One-carbon metabolism protect glioma cells under glutamine starvation through upregulation of MTHFD2
por: Tanaka, Kazuhiro, et al.
Publicado: (2021)

COT-17 Cancer genomic medicine at Kobe University Hospital
por: Tanaka, Kazuhiro, et al.
Publicado: (2020)

CBMS-07 SERINE SYNTHESIS AND ONE-CARBON METABOLISM IN GLIOMA CELLS TO SURVIVE GLUTAMINE STARVATION
por: Tanaka, Kazuhiro, et al.
Publicado: (2019)

NI-10 Reclassification of diffuse gliomas based on molecular diagnosis -evaluation of methionine uptake and treatment outcome-
por: Tamura, Kaoru, et al.
Publicado: (2021)

NI-12 The ratio of T1-Weighted to T2-Weighted Signal Intensity and IDH mutation in glioma
por: Sanada, Takahiro, et al.
Publicado: (2021)

ET-12 ANTI-VEGF THERAPY WITH KETOGENIC DIET AGAINST GLIOBLASTOMA IN MOUSE MODEL
por: Sasayama, Takashi, et al.
Publicado: (2019)

Glioma cells require one-carbon metabolism to survive glutamine starvation
por: Tanaka, Kazuhiro, et al.
Publicado: (2021)

Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
por: Maeyama, Masahiro, et al.
Publicado: (2021)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

STMO-17 Treatment outcome of photodynamic therapy using talaporfin sodium for recurrent high-grade glioma
por: Ohno, Makoto, et al.
Publicado: (2021)

MPC-4 Malignant transformation of diffuse low-grade gliomas: systematic review and meta-analysis
por: Nakasu, Satoshi, et al.
Publicado: (2021)

IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
por: Akasaki, Yasuharu, et al.
Publicado: (2021)

NI-18 A Quantitative Analysis of Intraoperative 3T-Diffusion Tensor Imaging parameters for Functional Prediction with Motor Eloquent Glioma Patients
por: Kawataki, Tomoyuki, et al.
Publicado: (2021)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

ET-03 Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse midline glioma
por: Sasaki, Takahiro, et al.
Publicado: (2020)

ET-04 Enhancing drug delivery with MRI-guided focused ultrasound for diffuse intrinsic pontine glioma model
por: Ishida, Joji, et al.
Publicado: (2020)

NI-01 Usefulness of preoperative evaluation of glioma elasticity by the magnetic resonance elastography
por: Koizumi, Shinichiro, et al.
Publicado: (2020)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

NI-13 Prediction of outcome at the time of discontinuing TMZ-adjuvant therapy in IDH-mutant lower grade glioma using (11)C-methinine PET
por: Beppu, Takaaki, et al.
Publicado: (2021)

ET-9 Development of photosensitive antibodies for near-infrared light immunotherapy targeting EGFR and IL13Rα2 of malignant gliomas and investigation of their photodynamic cytotoxic activity in vitro
por: Nonoguchi, Naosuke, et al.
Publicado: (2021)

NI-09 Amide Proton Transfer (APT) image is useful for diagnostic imaging of glioma
por: Shirota, Masami, et al.
Publicado: (2020)

NI-8 Molecular diagnostic prediction combining T2-FLAIR mismatch sign, calcification, and methionine PET in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2021)

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults
por: Takeshima, Yuki, et al.
Publicado: (2021)

OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment
por: Varn, Frederick, et al.
Publicado: (2021)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA
por: Odia, Yazmin, et al.
Publicado: (2022)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences
por: Lietke, Stefanie, et al.
Publicado: (2021)

RT-1 Treatment results of salvage gamma knife stereotactic radiosurgery and bevacizumab (AVAgamma therapy) for recurrent malignant glioma
por: Sato, Kenichi, et al.
Publicado: (2021)

STMO-7 Usefulness of NU-KNIT in retractorless surgery for malignant glioma
por: Yamanaka, Yuji, et al.
Publicado: (2021)

ET-8 Integrated diagnostic approach to predict prognosis for malignant gliomas
por: Isoda, Masataka, et al.
Publicado: (2021)

GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients
por: Nakamizo, Satoshi, et al.
Publicado: (2013)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Radiographic occult cerebellar germinoma presenting with progressive ataxia and cranial nerve palsy
por: Minami, Noriaki, et al.
Publicado: (2016)

DDRE-30. THERAPEUTIC TARGETING OF DISRUPTED METABOLIC STATE IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Mbah, Nneka, et al.
Publicado: (2021)

DDRE-32. THERAPEUTIC TARGETING OF A NOVEL METABOLIC ADDICTION IN DIFFUSE MIDLINE GLIOMA
por: Pal, Sharmistha, et al.
Publicado: (2021)

DDRE-18. THE MITOCHONDRIAL PYRUVATE CARRIER—A METABOLIC TARGET OF MALIGNANT GLIOMA
por: Tiburcio, Patricia, et al.
Publicado: (2021)

Multi‐marker algorithms based on CXCL13, IL‐10, sIL‐2 receptor, and β2‐microglobulin in cerebrospinal fluid to diagnose CNS lymphoma
por: Maeyama, Masahiro, et al.
Publicado: (2020)

CLRM-05 FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS
por: Dalmage, Mahalia, et al.
Publicado: (2022)

MET-08 Air in cistern or ventricle after brain metastasis surgery is a predictor of early postoperative intracranial recurrence
por: Ikeuchi, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ddpblqp4dnft40ae22e65n0itn